PortfoliosLab logo
PAHC vs. BSX
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between PAHC and BSX is 0.37, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

PAHC vs. BSX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Phibro Animal Health Corporation (PAHC) and Boston Scientific Corporation (BSX). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

PAHC:

0.82

BSX:

1.76

Sortino Ratio

PAHC:

1.44

BSX:

2.29

Omega Ratio

PAHC:

1.17

BSX:

1.37

Calmar Ratio

PAHC:

0.56

BSX:

2.61

Martin Ratio

PAHC:

2.73

BSX:

10.62

Ulcer Index

PAHC:

13.12%

BSX:

3.81%

Daily Std Dev

PAHC:

48.07%

BSX:

22.34%

Max Drawdown

PAHC:

-79.60%

BSX:

-89.15%

Current Drawdown

PAHC:

-45.96%

BSX:

-2.02%

Fundamentals

Market Cap

PAHC:

$991.45M

BSX:

$157.07B

EPS

PAHC:

$0.78

BSX:

$1.39

PE Ratio

PAHC:

31.36

BSX:

76.38

PEG Ratio

PAHC:

1.66

BSX:

2.57

PS Ratio

PAHC:

0.83

BSX:

8.95

PB Ratio

PAHC:

3.54

BSX:

6.96

Total Revenue (TTM)

PAHC:

$1.19B

BSX:

$17.55B

Gross Profit (TTM)

PAHC:

$376.71M

BSX:

$11.79B

EBITDA (TTM)

PAHC:

$128.96M

BSX:

$4.09B

Returns By Period

The year-to-date returns for both stocks are quite close, with PAHC having a 17.25% return and BSX slightly lower at 17.01%. Over the past 10 years, PAHC has underperformed BSX with an annualized return of -1.38%, while BSX has yielded a comparatively higher 19.05% annualized return.


PAHC

YTD

17.25%

1M

32.94%

6M

4.38%

1Y

38.98%

3Y*

11.27%

5Y*

1.39%

10Y*

-1.38%

BSX

YTD

17.01%

1M

2.28%

6M

15.16%

1Y

39.03%

3Y*

36.38%

5Y*

22.43%

10Y*

19.05%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Phibro Animal Health Corporation

Boston Scientific Corporation

Go deeper with the Portfolio Analysis tool — backtest performance, assess risk, compare to benchmarks, and more

Risk-Adjusted Performance

PAHC vs. BSX — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PAHC
The Risk-Adjusted Performance Rank of PAHC is 7575
Overall Rank
The Sharpe Ratio Rank of PAHC is 7878
Sharpe Ratio Rank
The Sortino Ratio Rank of PAHC is 7575
Sortino Ratio Rank
The Omega Ratio Rank of PAHC is 7171
Omega Ratio Rank
The Calmar Ratio Rank of PAHC is 7474
Calmar Ratio Rank
The Martin Ratio Rank of PAHC is 7777
Martin Ratio Rank

BSX
The Risk-Adjusted Performance Rank of BSX is 9393
Overall Rank
The Sharpe Ratio Rank of BSX is 9393
Sharpe Ratio Rank
The Sortino Ratio Rank of BSX is 8989
Sortino Ratio Rank
The Omega Ratio Rank of BSX is 9292
Omega Ratio Rank
The Calmar Ratio Rank of BSX is 9595
Calmar Ratio Rank
The Martin Ratio Rank of BSX is 9595
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

PAHC vs. BSX - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Phibro Animal Health Corporation (PAHC) and Boston Scientific Corporation (BSX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current PAHC Sharpe Ratio is 0.82, which is lower than the BSX Sharpe Ratio of 1.76. The chart below compares the historical Sharpe Ratios of PAHC and BSX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Go to the full Sharpe Ratio tool to analyze any stock or portfolio. Customize time frames, set your own risk-free rate, and more

Dividends

PAHC vs. BSX - Dividend Comparison

PAHC's dividend yield for the trailing twelve months is around 1.96%, while BSX has not paid dividends to shareholders.


TTM20242023202220212020201920182017201620152014
PAHC
Phibro Animal Health Corporation
1.96%2.29%4.15%3.58%2.35%2.47%1.93%1.31%1.19%1.37%1.33%0.63%
BSX
Boston Scientific Corporation
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

PAHC vs. BSX - Drawdown Comparison

The maximum PAHC drawdown since its inception was -79.60%, smaller than the maximum BSX drawdown of -89.15%. Use the drawdown chart below to compare losses from any high point for PAHC and BSX.


Loading data...

Go to the full Drawdowns tool for more analysis options, including inflation-adjusted drawdowns, and more

Volatility

PAHC vs. BSX - Volatility Comparison

Phibro Animal Health Corporation (PAHC) has a higher volatility of 18.84% compared to Boston Scientific Corporation (BSX) at 4.51%. This indicates that PAHC's price experiences larger fluctuations and is considered to be riskier than BSX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

PAHC vs. BSX - Financials Comparison

This section allows you to compare key financial metrics between Phibro Animal Health Corporation and Boston Scientific Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.001.00B2.00B3.00B4.00B5.00B20212022202320242025
347.83M
4.66B
(PAHC) Total Revenue
(BSX) Total Revenue
Values in USD except per share items

PAHC vs. BSX - Profitability Comparison

The chart below illustrates the profitability comparison between Phibro Animal Health Corporation and Boston Scientific Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

30.0%40.0%50.0%60.0%70.0%20212022202320242025
30.1%
68.8%
(PAHC) Gross Margin
(BSX) Gross Margin
PAHC - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Phibro Animal Health Corporation reported a gross profit of 104.57M and revenue of 347.83M. Therefore, the gross margin over that period was 30.1%.

BSX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Boston Scientific Corporation reported a gross profit of 3.21B and revenue of 4.66B. Therefore, the gross margin over that period was 68.8%.

PAHC - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Phibro Animal Health Corporation reported an operating income of 33.52M and revenue of 347.83M, resulting in an operating margin of 9.6%.

BSX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Boston Scientific Corporation reported an operating income of 921.00M and revenue of 4.66B, resulting in an operating margin of 19.8%.

PAHC - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Phibro Animal Health Corporation reported a net income of 20.88M and revenue of 347.83M, resulting in a net margin of 6.0%.

BSX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Boston Scientific Corporation reported a net income of 674.00M and revenue of 4.66B, resulting in a net margin of 14.5%.